SCHEMBL14720649

SCHEMBL14720649

CN1CCN(Cc2ccc(C=C3CCN(C4CCC4)CC3)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 2/20 0.35
SRD5A2 P31213 1/20 0.35
HRH3 Q9Y5N1 6/20 0.35
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
LMNA P02545 1/20 0.33
CYP2D6 P10635 1/20 0.33
GRM2 Q14416 1/20 0.33
TP53BP1 Q12888 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14721179 0.82 L3MBTL1 (0.50) SRD5A2HRH3CYP2D6TP53BP1L3MBTL3
SCHEMBL14720463 0.82 L3MBTL1 (0.47) SRD5A2HRH3ALDH1A1L3MBTL1KMT2A
SCHEMBL14722442 0.80 GRM2 (0.47) SRD5A2HRH3SMN1; SMN2GRM2L3MBTL3
SCHEMBL14720875 0.79 FKBP1A (0.38) FKBP1ASRD5A2HRH3
SCHEMBL14720876 0.79 FKBP1A (0.38) FKBP1ASRD5A2HRH3
SCHEMBL14720707 0.79 SRD5A1 (0.43) SRD5A2ALDH1A1LMNACYP2D6GRM2
SCHEMBL14720854 0.78 HRH3 (0.40) SRD5A2HRH3GRM2L3MBTL1
SCHEMBL14721980 0.78 HRH3 (0.43) SRD5A2HRH3SMN1; SMN2L3MBTL3L3MBTL1
SCHEMBL14720525 0.78 PDE4A (0.35) FKBP1ASRD5A2ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL14720524 0.78 PDE4A (0.35) FKBP1ASRD5A2ALDH1A1SMN1; SMN2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed